Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Goodwill & Intangibles (2017 - 2025)

Historic Goodwill & Intangibles for Ultragenyx Pharmaceutical (RARE) over the last 9 years, with Q3 2025 value amounting to $217.3 million.

  • Ultragenyx Pharmaceutical's Goodwill & Intangibles rose 382.19% to $217.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $217.3 million, marking a year-over-year increase of 382.19%. This contributed to the annual value of $222.7 million for FY2024, which is 208.04% up from last year.
  • Latest data reveals that Ultragenyx Pharmaceutical reported Goodwill & Intangibles of $217.3 million as of Q3 2025, which was up 382.19% from $219.1 million recorded in Q2 2025.
  • Ultragenyx Pharmaceutical's 5-year Goodwill & Intangibles high stood at $222.7 million for Q4 2024, and its period low was $175.3 million during Q3 2021.
  • Its 5-year average for Goodwill & Intangibles is $203.0 million, with a median of $204.4 million in 2022.
  • Per our database at Business Quant, Ultragenyx Pharmaceutical's Goodwill & Intangibles surged by 1849.94% in 2022 and then crashed by 54.19% in 2023.
  • Ultragenyx Pharmaceutical's Goodwill & Intangibles (Quarter) stood at $175.7 million in 2021, then rose by 18.5% to $208.2 million in 2022, then increased by 4.8% to $218.2 million in 2023, then increased by 2.08% to $222.7 million in 2024, then dropped by 2.41% to $217.3 million in 2025.
  • Its Goodwill & Intangibles was $217.3 million in Q3 2025, compared to $219.1 million in Q2 2025 and $220.9 million in Q1 2025.